Safety of sputum induction during exacerbations of COPD

Chest

Volumn 131, Issue 2, 2007, Pages 432-438

  Bathoorn, Erik ^a   Liesker, Jeroen ^a   Postma, Dirkje ^a   Koëter, Gerard ^a   Van Oosterhout, Antoon J M ^a   Kerstjens, Huib A M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

COPD; Exacerbation; Safety; Sputum induction

Indexed keywords

ADULT; AGED; ARTICLE; CELL COUNT; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATORY CELL; LUNG FUNCTION; MALE; PATIENT SAFETY; PRIORITY JOURNAL; SPUTUM EXAMINATION;

EID: 33847107694     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2216     Document Type: Article

References (23)

1. Rutgers SR, Timens W, Kaufmann HF et al. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000; 15:109-115
2. Pizzichini E, Pizzichini MM, Leigh R et al. Safety of sputum induction. Eur Respir J Suppl 2002; 37:9s-18s
3. Jayaram L, Parameswaran K, Sears MR, et al. Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J 2000; 16:150-158
4. Bhowmik A, Seemungal TA, Sapsford RJ, et al. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax 1998; 53:953-956
5. Vlachos-Mayer H, Leigh R, Sharon RF, et al. Success and safety of sputum induction in the clinical setting. Eur Respir J 2000; 16:997-1000
6. Sutherland ER, Pak J, Langmack EL, et al. Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease. Respir Med 2002; 96:482-486
7. Brightling CE, Monterio W, Green RH, et al. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med 2001; 95:999-1002
8. Rytila PH, Lindqvist AE, Laitinen LA. Safety of sputum induction in chronic obstructive pulmonary disease. Eur Respir J 2000; 15:1116-1119
9. Taube C, Holz O, Mucke M, et al. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic-obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:1810-1815
10. Pizzichini MM, Pizzichini E, Clelland L, et al. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med 1997; 155:1501-1508
11. Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999; 354:456-460
12. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows: report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal; official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:5-40
13. Meijer RJ, Kerstjens HA, Arends LR, et al. Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax 1999; 54: 894-899
14. Fahy JV, Boushey HA, Lazarus SC, et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001; 163: 1470-1475
15. Twaddell SH, Gibson PG, Carty K, et al. Assessment of airway inflammation in children with acute asthma using induced sputum. Eur Respir J 1996; 9:2104-2108
16. Bhowmik A, Seemungal TA, Sapsford RJ, et al. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax 1998; 53:953-956
17. Aaron SD, Angel JB, Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:349-155
18. Bhowmik A, Seemungal TA, Sapsford RJ, et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000; 55:114-120
19. Fujimoto K, Yasuo M, Urushibata K, et al. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 2005; 25:640-646
20. Holz O, Jorres RA, Koschyk S, et al. Changes in sputum composition during sputum induction in healthy and asthmatic subjects. Clin Exp Allergy 1998; 28:284-292
21. Belda J, Hussack P, Dolovich M, et al. Sputum induction: effect of nebulizer output and inhalation time on cell counts and fluid-phase measures. Clin Exp Allergy 2001; 31:1740-1744
22. Kelly MG, Brown V, Martin SL, et al. Comparison of sputum induction using high-output and low-output ultrasonic nebulizers in normal subjects and patients with COPD. Chest 2002; 122:955-959
23. Papi A, Romagnoli M, Baraldo S, et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162:1773-1777